These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


439 related items for PubMed ID: 18279751

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
    Callenbach PM, Arts WF, ten Houten R, Augustijn P, Gunning WB, Peeters EA, Weber AM, Stroink H, Geerts Y, Geerts AT, Brouwer OF.
    Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Intravenous levetiracetam in the management of acute seizures in children.
    Reiter PD, Huff AD, Knupp KG, Valuck RJ.
    Pediatr Neurol; 2010 Aug; 43(2):117-21. PubMed ID: 20610122
    [Abstract] [Full Text] [Related]

  • 6. Levetiracetam monotherapy in children with epilepsy.
    Khurana DS, Kothare SV, Valencia I, Melvin JJ, Legido A.
    Pediatr Neurol; 2007 Apr; 36(4):227-30. PubMed ID: 17437904
    [Abstract] [Full Text] [Related]

  • 7. High-dose intravenous levetiracetam for acute seizure exacerbation in children with intractable epilepsy.
    Depositario-Cabacar DT, Peters JM, Pong AW, Roth J, Rotenberg A, Riviello JJ, Takeoka M.
    Epilepsia; 2010 Jul; 51(7):1319-22. PubMed ID: 20163437
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Intravenous levetiracetam in acute repetitive seizures and status epilepticus in children: experience from a children's hospital.
    McTague A, Kneen R, Kumar R, Spinty S, Appleton R.
    Seizure; 2012 Sep; 21(7):529-34. PubMed ID: 22722010
    [Abstract] [Full Text] [Related]

  • 10. Use of intravenous levetiracetam for management of acute seizures in neonates.
    Khan O, Chang E, Cipriani C, Wright C, Crisp E, Kirmani B.
    Pediatr Neurol; 2011 Apr; 44(4):265-9. PubMed ID: 21397167
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of levetiracetam as an add-on therapy in children aged less than 4 years with refractory epilepsy.
    Li S, Cao J, Xiao N, Cai F.
    J Child Neurol; 2010 May; 25(5):609-13. PubMed ID: 19779208
    [Abstract] [Full Text] [Related]

  • 13. Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP, Ricker L, Diepman L, Gehring J, Hulsman J, Lambrechts D, Leenen L, Majoie M, Schellekens A, de Krom M, Aldenkamp AP.
    Epilepsy Behav; 2007 Mar; 10(2):296-303. PubMed ID: 17317325
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy of levetiracetam in children with epilepsy younger than 2 years of age.
    Krief P, Li Kan, Maytal J.
    J Child Neurol; 2008 May; 23(5):582-4. PubMed ID: 18448575
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.